Mark Lang to Adjuvants, Immunologic
This is a "connection" page, showing publications Mark Lang has written about Adjuvants, Immunologic.
Connection Strength
1.113
-
BAFF- and APRIL-dependent maintenance of antibody titers after immunization with T-dependent antigen and CD1d-binding ligand. J Immunol. 2013 Aug 01; 191(3):1154-63.
Score: 0.427
-
Type II NKT cells facilitate Alum-sensing and humoral immunity. J Leukoc Biol. 2012 Oct; 92(4):883-93.
Score: 0.400
-
Local Phototherapy Synergizes with Immunoadjuvant for Treatment of Pancreatic Cancer through Induced Immunogenic Tumor Vaccine. Clin Cancer Res. 2018 11 01; 24(21):5335-5346.
Score: 0.152
-
CD1d-dependent B-cell help by NK-like T cells leads to enhanced and sustained production of Bacillus anthracis lethal toxin-neutralizing antibodies. Infect Immun. 2010 Apr; 78(4):1610-7.
Score: 0.084
-
Peptide Aggregation Induced Immunogenic Rupture (PAIIR). Adv Sci (Weinh). 2022 07; 9(21):e2105868.
Score: 0.049